It is worth noting that peptides based on the PEGylated sequence of TSPYL5113–125 (TS120) have shown a strong impact on metastatic abilities (invasion/migration), sphere-forming capacity, and colony formation ability of A549 lung cancer cells, making TSPYL5 a potential target for the treatment of oncological diseases [8]. This evidence concerns the gene TSPYL5 and lung cancer.